Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania

Table 4 Comparison of oral lesions among adults on HAART (n = 276) and those not on HAART (n = 205)

Type of oral lesions	No. of oral lesions n (%)	Unadjusted OR (95% CI)	Adjusted OR (95% CI)	p-value
Oral candidiasis
On HAART	41 (14.9)	0.28 (0.18–	0.17 (0.11–0.28)	0.00
Not on HAART	78 (38.0)	0.44)
Hyper pigmentation
On HAART	17 (6.2)	1.62 (0.68–	1.60 (0.67–3.81)	0.27
Not on HAART	8 (3.9)	3.82)
Enlarged Parotid gland
On HAART	6 (2.2)	0.89 (0.27–	0.92 (0.27–3.10)	0.85
Not on HAART	5 (4.9)	2.95)
Oral Kaposi's sarcoma
On HAART	5 (1.8)	0.36 (0.12–	0.29 (0.10–0.89)	0.06
Not on HAART	10 (4.9)	1.06)		*(0.03)
Necrotizing Ulcerative gingivitis
On HAART	5 (1.7)	0.45 (0.15–1.41)	0.37 (0.12–1.15)	0.17
Not on HAART	8 (3.4)
Oral hairy leukoplakia
On HAART	2 (0.7)	0.18 (0.04–	0.15 (0.03–0.70)	0.03
Not on HAART	8 (3.9)	0.85)
Herpes simplex lesions
On HAART	3 (1.1)	0.44 (0.10–	0.39 (0.09–1.69)	0.26
Not on HAART	5 (2.4)	1.86)
Recurrent ulcers
On HAART	1 (0.4)	0.24 (0.02–	0.22 (0.02–2.15)	0.22
Not on HAART	3 (1.54)	2.37)
Oral warts
On HAART	2 (0.7)	1.49 (0.13–	1.44 (0.13–16.4)	0.75
Not on HAART	1 (0.5)	16.5)
Bell's palsy
On HAART	0 (0.0)	-	-	0.84
Not on HAART	3 (1.5)
Herpes zoster face
On HAART	0 (0.0)	-	-	0.85
Not on HAART	2 (0.9)
Odontogenic abscess
On HAART	1 (0.4)	0.74 (0.04–11.9)	0.78 (0.05–13.0)	0.83
Not on HAART	1 (0.5)

ISSN: 1472-6831